# Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

> **NCT04782388** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 30 (actual)

## Conditions studied

- Healthy Study Participants

## Interventions

- **DRUG:** Alprazolam
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04782388
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-04
- **Primary completion:** 2021-04-26
- **Final completion:** 2021-04-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04782388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04782388, "Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT04782388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*